United Kingdom, May 12 -- Weight-loss injections could help to reduce the risk of cancer.

That is according to a new study, which suggests that weight-loss jabs, officially GLP-1 receptor agonists, could almost halve the risk of obesity-related cancers.

Dr Yael Wolff Sagy, the study's co-lead author, said: "We do not yet fully understand how GLP-1s work, but this study adds to the growing evidence showing that weight loss alone cannot completely account for the metabolic, anti-cancer, and many other benefits that these medications provide."

The NHS claims that obesity is the second biggest cause of cancer in the UK. Obesity actually causes more than one in 20 cancer cases, according to the NHS.

But the recent research found that weigh...